The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Lexaria Bioscience's share price is $3.09.
Lexaria Bioscience's Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2024 was $0.04. Hence, Lexaria Bioscience's PS Ratio for today is 70.23.
The historical rank and industry rank for Lexaria Bioscience's PS Ratio or its related term are showing as below:
LEXX'
s PS Ratio Range Over the Past 10 Years
Min: 0.52 Med: 102.63 Max: 1496.07
Current: 57.74
During the past 13 years, Lexaria Bioscience's highest PS Ratio was 1496.07. The lowest was 0.52. And the median was 102.63.
LEXX's PS Ratio is ranked worse than 80.36% of 993
companies
in the Biotechnology industry
Industry Median: 9.09
vs LEXX: 57.74
Lexaria Bioscience Corp revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Lexaria Bioscience was -20.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -37.50% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -25.50% per year.
During the past 13 years, Lexaria Bioscience's highest 3-Year average Revenue per Share Growth Rate was 155.30% per year. The lowest was -83.20% per year. And the median was -8.55% per year.
Back to Basics: PS Ratio
Lexaria Bioscience PS Ratio Historical Data
The historical data trend for Lexaria Bioscience's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Lexaria Bioscience's PS Ratio
For the Biotechnology subindustry, Lexaria Bioscience's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lexaria Bioscience's PS Ratio Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Lexaria Bioscience's PS Ratio distribution charts can be found below:
* The bar in red indicates where Lexaria Bioscience's PS Ratio falls into.
Lexaria Bioscience PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Lexaria Bioscience's Share Price of today is $3.09. Lexaria Bioscience's Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.04.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Lexaria Bioscience (NAS:LEXX) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Lexaria Bioscience PS Ratio Related Terms
Thank you for viewing the detailed overview of Lexaria Bioscience's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Lexaria Bioscience (Lexaria Bioscience) Business Description
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. The Company has four reportable segments: Intellectual Property Licensing, B2B Production, Research and Development and Corporate. It earns maximum revenue from Intellectual Property Licensing.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LEXX has been successfully added to your 